Mylotarg (Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.)
Welcome to the PulseAid listing for the Mylotarg drug offered from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.. This CD33-directed Cytotoxin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| NON-PROPRIETARY NAME: | gemtuzumab ozogamicin |
| SUBSTANCE NAME: | GEMTUZUMAB OZOGAMICIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | CD33-directed Cytotoxin [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2017-09-07 |
| END MARKETING DATE: | 0000-00-00 |
Mylotarg HUMAN PRESCRIPTION DRUG Details:
| Item Description | Mylotarg from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| LABELER NAME: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/5mL) |
| START MARKETING DATE: | 2017-09-07 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0008-4510_da94b46a-1ee4-476a-bd6f-e60c52918c52 |
| PRODUCT NDC: | 0008-4510 |
| APPLICATION NUMBER: | BLA761060 |
Other GEMTUZUMAB OZOGAMICIN Pharmaceutical Manufacturers / Labelers:
